Utah Medical Launches $75 Self-Tender for 20% of Shares
UTMD sits 31% above its 52-week low of $53.66 on light trading volume (0.2× avg).
Summary
Utah Medical Products is launching a self-tender offer to buy back up to 650,000 shares at $75 each, roughly 20% of shares outstanding. The offer starts September 22 and runs 15 business days, with odd-lot priority and pro rata if oversubscribed. The $75 price is 17% above the one-year average close, setting a near-term anchor and potential upside toward that level. The company may purchase more than 650,000 shares and there is no minimum tender condition, reducing execution risk. This follows a difficult Q2 with revenue down 14% and guidance slashed, so the tender signals confidence and a capital return to shareholders. Watch for take-up rate and any upsizing after the offer closes.
At the time of this announcement, UTMD was trading at $70.35 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $224M. The 52-week trading range was $53.66 to $75.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.